Hearing held on proposal to make human ivermectin available over the counter
Representative Mavic presented LC520943 to allow human-formulation ivermectin to be sold OTC; sponsors cited global uses and safety profile, members asked about FDA approval and warning labels, and the committee held the item as a hearing-only matter.
The full story
Representative Mavic introduced LC520943, a hearing-only proposal brought by constituents to permit over-the-counter sale of human-formulation ivermectin. The sponsor described ivermectin as an anti-parasitic drug developed in 1980 and approved by the FDA for certain uses, and said it has an excellent safety profile for indicated uses. The sponsor acknowledged that the FDA has not approved ivermectin for COVID-19 treatment and cited contraindications including pregnancy, breastfeeding and interactions with certain medications.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in